SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Orexigen Therapeutics, Inc. and Certain Officers -- OREX

NEW YORK, March 11, 2015 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Orexigen Therapeutics, Inc. ("Orexigen" or the "Company") (Nasdaq: OREX ) and certain of its officers. The class action, filed in United States District Court, Southern District of California, is on behalf of a class consisting of all persons or entities who purchased Orexigen securities between March 3, 2015 and March 5, 2015, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"). 

If you are a shareholder who purchased Orexigen securities during the Class Period, you have until May 11, 2015 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Orexigen is a biopharmaceutical company that focuses on the development of pharmaceutical product candidates for the treatment of obesity.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, and failed to disclose material adverse facts about the Company's business, operations, prospects and performance. Specifically, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) study results released by Orexigen, showing that its obesity drug Contrave reduced the risk of heart attacks and cardiovascular death, were unreliable and misleading; (ii) as such, Orexigen faced potential fines, civil penalties, and the possible removal of Contrave from the market; and (iii) as a result of the above, the Company's financial statements were materially false and misleading at all relevant times.

On March 3, 2015, the Company filed a Form 8-K with the SEC, announcing a patent application with the United States Patent and Trademark Office. In the patent application, the Company disclosed positive interim results of an ongoing clinical trial of its weight loss drug Contrave. As a result of this news, the Company's shares increased $1.85 or almost 32%, to close at $7.64 on March 3, 2015. The next day, shares rose $0.85 or over 11%, to close at $8.49 on March 4, 2015. The total increase over two days was $2.70, or over 46%. However, the interim data published by the Company was particularly unreliable, as noted in numerous articles published in the days after the patent application was filed. 

Takeda, which has an agreement with Orexigen to market Contrave in the United States, released a statement on March 5, 2015, stating that it did not support the release of the interim data.

On the news, shares in Orexigen fell $0.48 or almost 6%, to close at $8.01 on March 5, 2015.

After the close of trading on March 5, 2015, in a report published on Forbes.com , a top FDA official criticized Orexigen and its decision to release interim trial data. In the report, Dr. John Jenkins, the FDA's director of the Office of New Drugs criticized the released data as "unreliable," "misleading," and "likely false." He also said that the results must be kept confidential to avoid compromising the trial's integrity so researchers can get a clear sense of any cardiovascular risk related to the drug.

On this news, shares in Orexigen fell as much as $1.25, or almost 16%, to as low as $6.76 in intraday trading on March 6, 2015.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

Robert S. Willoughby Pomerantz LLP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 166

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 129

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 112

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 111

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 131

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Blast Doubles Athabasca Ground, but Drills Still Matter

Updated Category News Views 75

More ground in Athabasca can wake up a uranium junior fast, and Blast Resources has certainly grabbed investors’ attention with this one. The company has optioned eight additional uranium claims beside its Wales Lake property in northern Saskatchewan, taking its regional footprint from 12,150 hectares across 16 claims to 30,732 hectares across 24 claims. That is more...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 199

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 122

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading
Live Nation Tests Creator Content With Morgan Jay Series

Updated Category News Views 157

A comedian turning crowd work into songs is hardly a boardroom event, but this one has a useful wrinkle: Live Nation Studios put financing behind it. Morgan Jay and Austin-based agency Hello Party launched Music Therapy with Morgan Jay on YouTube on November 18, with Kam Patterson opening the season. The show pairs Jay and celebrity guests for loose conversation,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlueVoyant Launches Innovative Cybersecurity Solution for Enterprises

Updated Category News Views 249

BlueVoyant Introduces a Cutting-Edge Cybersecurity Solution BlueVoyant has launched its Continuous Optimization for Microsoft Security (COMS) service, marking a significant step in enterprise cybersecurity. This innovative solution is crafted to empower organizations with advanced threat detection and optimization strategies for Microsoft Security tools. Clients benefit...

Continue Reading
Prudential Advisors Welcomes New Talent and Grows Nationally

Updated Category News Views 224

Prudential Advisors' Remarkable Growth in 2025 Prudential Advisors is on an exciting journey, having welcomed an impressive wave of experienced financial advisors, significantly bolstering their national influence. Incorporating skilled advisors managing an astounding $3 billion in client assets marks a pivotal milestone for the firm. With nearly a 9% rise in advisor...

Continue Reading
Investors Unite: Solaris Energy Faces Class Action Lawsuit

Updated Category News Views 351

Understanding the Class Action Lawsuit Against Solaris Energy Infrastructure Recent developments have brought attention to Solaris Energy Infrastructure, Inc. and its ongoing class action lawsuit. Shareholders are encouraged to stand up for their rights as allegations arise concerning the company's practices and communications with investors. Details of the Allegations...

Continue Reading
Raising Awareness for Emergency Notification System Signs

Updated Category News Views 145

Understanding Emergency Notification System Signs As part of an ongoing effort to enhance safety at railroad crossings, Operation Lifesaver, Inc. (OLI), an esteemed national nonprofit dedicated to rail safety education, is launching its inaugural Emergency Notification System (ENS) Sign Awareness Day. This event is not just a one-time notice; it's an encouragement for all...

Continue Reading
Veolia and Mistral AI Unite to Transform Ecological Management

Updated Category News Views 361

Revolutionizing Resource Management with Generative AI Veolia, a prominent name in ecological transformation, is making waves by collaborating with Mistral AI, a leader in generative artificial intelligence. Their recent strategic partnership aims to redefine the management of industrial sites, focusing on water management, waste recycling, and local energy production....

Continue Reading